Nykode Therapeutics Denmark A/S: Financial statements 2025
CVR: 42038660
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Nykode Therapeutics Denmark A/S (CVR 42038660) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 31,839,001 and a net result of DKK 1,347,127 compared with DKK 156,959 the year before. That is a decrease of 49.9% compared with the year before. Equity in the 2025 report amounted to DKK 6,862,099. The solvency ratio was 44.1%. The company had 16 employees in the financial year.
- Gross Profit
- DKK 31,839,001
- Profit/Loss
- DKK 1,347,127
- Equity
- DKK 6,862,099
- Total Assets
- DKK 15,551,490
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 31.8M | 1.3M | 6.9M | 16 |
| 2024 | - | 63.6M | 157K | 5.5M | 31 |
| 2023 | - | 52.9M | 2.5M | 5.4M | 31 |
| 2022 | - | 38.6M | 1.9M | 2.9M | 23 |
| 2021 | - | 10.6M | 578K | 978K | 7 |
Official annual report
How creditworthy is Nykode Therapeutics Denmark A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Nykode Therapeutics Denmark A/S has published its annual report for 2024. Gross profit came to DKK 63,552,511, and the net result was DKK 156,959.
About Nykode Therapeutics Denmark A/S
Nykode Therapeutics Denmark A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Vaccibody Denmark A/S. The management consists of Michael Thyrring Engsig. The board consists of Louise Stubbe (chair), Harald Gurvin and Michael Thyrring Engsig. The company is owned by Nykode Therapeutics ASA. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 31,839,001 and a net result of DKK 1,347,127 compared with DKK 156,959 the year before. Equity in the 2025 report amounted to DKK 6,862,099.
